G

Gurnet Point Capital

14 employees

Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies

Investor insights

Sectors invested in

Health Care6
Biotechnology5
Medical4
Liquid Biopsies for early detection2
Drug Discovery & Validation2
Patient & Drug Selection2
Therapeutics2
Pharmaceutical2
Near Site Health Clinics1
Biopharma1
Computer vision1
Fertility1
Artificial Intelligence1
In Vitro Fertilization1
Reproductive Medicine1
Infertility1
Machine Learning1
AI1
Pregnancy1
Family-building1

Funding rounds participated in

$60M sweet spot round size

Most of their 10 investments are in rounds between $33M and $92M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

investment management

Sectors

Biotechnology
Medical Device
Health Care
Pharmaceutical

Date founded

2015

Investments made

C

Corium International, Inc. raised undisclosed on October 20, 2022

Investors: Gurnet Point Capital

N

NAVERIS raised $33M on September 19, 2022

Investors: Gurnet Point Capital

A

Alladapt Immunotherapeutics, Inc. raised $119M on June 22, 2022

Investors: Red Tree Venture Capital, Patient Square Capital, WestRiver Group and Gurnet Point Capital

F

Fairtility raised $15M on May 23, 2022

Investors: Nacre Capital and Gurnet Point Capital

N

NAVERIS raised undisclosed on December 15, 2020

Investors: Sky Ventures Group and Gurnet Point Capital

T

Tremeau Pharmaceuticals, Inc. raised $110M on December 9, 2020

Investors: Gurnet Point Capital

A

Alladapt Immunotherapeutics, Inc. raised $60M on February 20, 2020

Investors: TRB Advisors LP, Camino Partners (formerly Equilibra) and Gurnet Point Capital

B

Before Brands, Inc. raised $35M on March 20, 2017

Investors: Gurnet Point Capital

C

Crossover Health raised $92M on December 7, 2016

Investors: Gurnet Point Capital

A

Auregen BioTherapeutics raised undisclosed on December 1, 2016

Investors: Gurnet Point Capital

FAQ